{"id":"NCT01135914","sponsor":"Novartis Pharmaceuticals","briefTitle":"Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)","officialTitle":"A Canadian 12-month, Prospective, Randomized, Open-label, Multicenter, Laser-controlled Phase IIIb Study Assessing the Efficacy, Safety and Cost-efficacy of Ranibizumab as Combination and Monotherapy in Patients With Visual Impairment Due to Diabetic Macular Edema.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-07","primaryCompletion":"2013-03","completion":"2013-03","firstPosted":"2010-06-03","resultsPosted":"2014-10-23","lastUpdate":"2014-10-23"},"enrollment":241,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetic Macular Edema"],"interventions":[{"type":"DRUG","name":"ranibizumab","otherNames":[]},{"type":"PROCEDURE","name":"Laser","otherNames":[]}],"arms":[{"label":"Combination Therapy","type":"EXPERIMENTAL"},{"label":"Ranibizumab Monotherapy","type":"EXPERIMENTAL"},{"label":"Laser Monotherapy","type":"ACTIVE_COMPARATOR"}],"summary":"To evaluate, specifically within the Canadian medical environment, the efficacy, safety and cost-efficacy of ranibizumab administered either as combination therapy (ranibizumab plus laser photocoagulation), or as monotherapy in comparison with the current standard of care (laser photocoagulation monotherapy), in patients with visual impairment due to DME.","primaryOutcome":{"measure":"Mean Change From Baseline in Best Corrected Visual Acuity- (BCVA) at Month 12","timeFrame":"Baseline and 12 months","effectByArm":[{"arm":"Combination Therapy","deltaMin":8.2,"sd":9.2},{"arm":"Ranibizumab Monotherapy","deltaMin":8.9,"sd":7.78},{"arm":"Laser Monotherapy","deltaMin":0.3,"sd":12.47}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":3},"locations":{"siteCount":20,"countries":["Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":73},"commonTop":["Intraocular pressure increased (Study eye)","Conjunctival haemorrhage (Study eye)","Nasopharyngitis","Hypertension","Intraocular pressure increased (Fellow eye)"]}}